Combination chemotherapy: The interaction of methotrexate and 5-fluorouracil
β Scribed by M.H.N. Tattersall; R.C. Jackson; T.A. Connors; K.R. Harrap
- Book ID
- 113145369
- Publisher
- Elsevier Science
- Year
- 1973
- Weight
- 599 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0014-2964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The CMF regimen, which is clinically used in adjuvant therapy of breast cancer, is known to be carcinogenic in rats (Habs and SchmΓ€hl, 1981). To examine alternative regimens, a longβterm carcinogenicity study was performed, using the VMF regimen as follows: V (i.v.), M (i.p.) and F (p.o
Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r